+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sulfur Hexafluoride Microbubbles for Injection Market by Application, End User, Product Type, Administration Route - Global Forecast to 2030- Product Image
Sulfur Hexafluoride Microbubbles for Injection Market by Application, End User, Product Type, Administration Route - Global Forecast to 2030- Product Image
Sale

Sulfur Hexafluoride Microbubbles for Injection Market by Application, End User, Product Type, Administration Route - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081426
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sulfur hexafluoride microbubbles are redefining diagnostic and therapeutic imaging, enabling healthcare providers to enhance patient care across key clinical specialties. Senior leaders seeking competitive advantage are closely monitoring this market’s rapid evolution, which is propelled by regulatory shifts, technology integration, and resilience strategies in global supply chains.

Market Snapshot of Sulfur Hexafluoride Microbubble Technology

With the sulfur hexafluoride microbubble market posting a noticeable compound annual growth rate and demonstrating considerable scale, the sector is securing early adoption among cardiology, neurology, radiology, and oncology service lines. Market momentum is attributed to regulatory approvals, innovation around microbubble formulations, expanding targeted applications, and a global push toward noninvasive imaging solutions. The ability to deliver enhanced ultrasound contrast, precise tissue perfusion insights, and support for patient-centric workflows is reshaping expectations among key healthcare stakeholders.

Scope & Segmentation

This report delivers comprehensive insight into sulfur hexafluoride microbubble market segmentation across key variables. The detailed segmentation framework addresses emerging clinical demands, technological requirements, and operational preferences:

  • Applications: Cardiovascular imaging optimizes myocardial studies; neurology leverages enhanced cerebral blood flow monitoring; oncology uses support tumor characterization and response assessment; radiology benefits from contrast-enhanced workflows.
  • End User Types: Ambulatory surgery centers add value through rapid perioperative imaging; diagnostic centers focus on protocol standardization; hospitals drive clinical adoption at scale; research institutes accelerate trial-based innovation.
  • Product Formats: Liquid options enable immediate readiness; powder forms offer greater shelf stability and ease of transport.
  • Administration Methods: Intra-arterial delivery suits localized intervention; intravenous infusion remains prevalent for systemic imaging needs.
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East, & Africa (including prominent Western Europe and emerging MEA markets such as United Kingdom, Germany, United Arab Emirates, and South Africa); Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asia’s expanding medical infrastructure).
  • Leading Companies: Bracco Imaging S.p.A., Lantheus Holdings, Inc., Jinhong Gas Co., Ltd., Solvay, Drägerwerk AG & Co. KGaA.

Key Takeaways for Senior Decision-Makers

  • Sulfur hexafluoride microbubble technology now underpins minimally invasive and real-time visualization, replacing ionizing imaging for greater patient safety and workflow efficiency.
  • Artificial intelligence and digital integration are streamlining image interpretation and anomaly detection, aligning the sector with precision medicine goals.
  • Molecular imaging and theranostic innovations are creating new clinical and commercial value across drug delivery and intervention monitoring.
  • Regional supply chain strategizing and dual-sourcing approaches are mitigating disruptions, supporting both cost control and supply continuity.
  • Collaborative models—linking device firms, pharmaceutical manufacturers, and research institutions—are enabling faster regulatory navigation and driving differentiated product launches.

Tariff Impact on Sulfur Hexafluoride Microbubble Production

Tariffs introduced in the United States for 2025 are reshaping sourcing and production routes. Increased import duties on specialty gases and chemical precursors have led manufacturers to intensify regional partnerships, invest in local gas generation, and emphasize recycling initiatives. These activities are fostering localized manufacturing hubs and advancing closed-loop gas recovery, which simultaneously support sustainability targets and transaction cost management. Market participants are realigning pricing strategies and deepening regulatory engagement to anticipate policy volatility.

Sulfur Hexafluoride Microbubble Market: Methodology & Data Sources

Research leverages a hybrid methodology, including primary interviews with frontline clinicians, regulatory experts, and C-suite executives. These insights are complemented by structured surveys from imaging departments, while secondary research covers scientific journals, regulatory filings, and guidance from international health agencies. Data triangulation and scenario analysis ensure validity and actionable intelligence, validated by an expert advisory panel.

Why This Report Matters

  • Arms decision-makers with a granular view of clinical and operational adoption drivers for sulfur hexafluoride microbubbles.
  • Delivers actionable recommendations for building supply chain resilience, accelerating product development, and forging strategic alliances in a complex regulatory environment.
  • Highlights regional opportunities so organizations can tailor investment and go-to-market strategies to maximize returns and operational agility.

Conclusion

Sulfur hexafluoride microbubbles, supported by ongoing innovation and strategic alignment, are integral to the future of patient-centric diagnostic and therapeutic imaging. Forward-looking organizations will capitalize by targeting growing clinical segments and forming cross-industry partnerships to secure marketplace relevance and sustained growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sulfur Hexafluoride Microbubbles for Injection Market, by Application Area
8.1. Introduction
8.2. Medical Diagnostic Imaging
8.2.1. Cardiovascular Imagery
8.2.2. Liver Function Assessment
8.3. Therapeutic Applications
8.3.1. Drug Delivery
9. Sulfur Hexafluoride Microbubbles for Injection Market, by End-User Industry
9.1. Introduction
9.2. Hospitals and Clinics
9.2.1. Diagnostic Centers
9.2.2. Outpatient Services
9.3. Research Organizations
9.3.1. Academic Institutions
9.3.2. Corporate Research Units
10. Sulfur Hexafluoride Microbubbles for Injection Market, by Product Type
10.1. Introduction
10.2. Concentration Kits
10.2.1. Patient-Specific Preparations
10.3. Ready-To-Inject Vials
10.3.1. Multi-Dose Units
10.3.2. Single-Dose Units
11. Americas Sulfur Hexafluoride Microbubbles for Injection Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Sulfur Hexafluoride Microbubbles for Injection Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Sulfur Hexafluoride Microbubbles for Injection Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Bracco Imaging S.p.A.
14.3.2. GE Healthcare
14.3.3. Lantheus Medical Imaging, Inc.
14.3.4. SonoVue (manufactured by Bracco)
14.3.5. Targeson, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET MULTI-CURRENCY
FIGURE 2. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET MULTI-LANGUAGE
FIGURE 3. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CARDIOVASCULAR IMAGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY LIVER FUNCTION ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CORPORATE RESEARCH UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PATIENT-SPECIFIC PREPARATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MULTI-DOSE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY SINGLE-DOSE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 59. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 60. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 61. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 62. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 63. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 64. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 65. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 67. CANADA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 69. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 70. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 106. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 107. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 108. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 110. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 111. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 112. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 114. CHINA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 115. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 116. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 117. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 119. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 120. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 121. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 123. INDIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 134. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 135. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 137. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 138. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 139. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 141. JAPAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 187. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 188. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 189. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 191. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 192. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 193. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 195. THAILAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 215. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 216. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 217. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 219. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 221. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 223. DENMARK SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 225. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 226. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 227. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 228. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 229. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 230. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 232. EGYPT SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 234. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 235. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 237. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 243. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 244. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 246. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY CONCENTRATION KITS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY READY-TO-INJECT VIALS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 252. GERMANY SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY MEDICAL DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 253. GERMANY SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 254. GERMANY SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 255. GERMANY SULFUR HEXAFLUORIDE MICROBUBBLES FOR INJECTION MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sulfur Hexafluoride Microbubbles for Injection market report include:
  • Bracco Imaging S.p.A.
  • Lantheus Holdings, Inc.
  • Jinhong Gas Co., Ltd.
  • Solvay
  • Drägerwerk AG & Co. KGaA

Related Topics

Related Reports

Sulfur Hexafluoride Market by Application, End Use Industry, Grade, Packaging, Distribution Channel - Global Forecast to 2030 - Product Image

Sulfur Hexafluoride Market by Application, End Use Industry, Grade, Packaging, Distribution Channel - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Sulfur Hexafluoride Gas Recovery System Market by Application, Technology, End User, Equipment Type, Sales Channel - Global Forecast to 2030 - Product Image

Sulfur Hexafluoride Gas Recovery System Market by Application, Technology, End User, Equipment Type, Sales Channel - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
2025 Sulfur Hexafluoride Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Sulfur Hexafluoride Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 153 Pages
  • Global
From
Sulfur Hexafluoride (SF6) - Global Strategic Business Report - Product Image

Sulfur Hexafluoride (SF6) - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Sulfur Hexafluoride - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Sulfur Hexafluoride - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.